Complete revascularization in acute myocardial infarction: a clinical review
- PMID: 36609898
- PMCID: PMC9823266
- DOI: 10.1007/s12928-022-00907-6
Complete revascularization in acute myocardial infarction: a clinical review
Abstract
In patients with ST segment elevation and non-ST elevation myocardial infarction (MI), multivessel (MV) coronary artery disease is found in approximately 50%, leading to worse clinical outcomes. Recent data have suggested that complete revascularization with MV percutaneous coronary intervention is associated with a reduced risk of major adverse cardiovascular events as compared to culprit vessel-only revascularization. However, the optimal timing of MV intervention, appropriate non-culprit lesion assessment, and the best revascularization strategy in specific subsets such as cardiogenic shock remain to be established. This review article summarizes current evidence on revascularization strategies in patients with acute MI and MV disease.
Keywords: Acute myocardial infarction; Complete revascularization; Percutaneous coronary intervention.
© 2023. The Author(s) under exclusive licence to Japanese Association of Cardiovascular Intervention and Therapeutics.
Conflict of interest statement
Yuichi Saito declares no conflicts of interest to disclose. Yoshio Kobayashi is a recipient of research grants from Abbott, Boston Scientific, Medtronic, Nipro, and Terumo.
Figures

Similar articles
-
Percutaneous coronary intervention strategies in patients with acute myocardial infarction and multivessel disease: Completeness, timing, lesion assessment, and patient status.J Cardiol. 2019 Aug;74(2):95-101. doi: 10.1016/j.jjcc.2019.04.001. Epub 2019 May 1. J Cardiol. 2019. PMID: 31053505 Review.
-
Culprit Vessel-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Cardiogenic Shock Complicating ST-Segment-Elevation Myocardial Infarction: A Collaborative Meta-Analysis.Circ Cardiovasc Interv. 2017 Nov;10(11):e005582. doi: 10.1161/CIRCINTERVENTIONS.117.005582. Circ Cardiovasc Interv. 2017. PMID: 29146672 Review.
-
Culprit-Only Revascularization, Single-Setting Complete Revascularization, and Staged Complete Revascularization in Acute Myocardial Infarction: Insights From a Mixed Treatment Comparison Meta-Analysis of Randomized Trials.Circ Cardiovasc Interv. 2024 Jul;17(7):e013737. doi: 10.1161/CIRCINTERVENTIONS.123.013737. Epub 2024 Jul 8. Circ Cardiovasc Interv. 2024. PMID: 38973504
-
Comparison of Long-Term Clinical Outcome Between Multivessel Percutaneous Coronary Intervention Versus Infarct-Related Artery-Only Revascularization for Patients With ST-Segment-Elevation Myocardial Infarction With Cardiogenic Shock.J Am Heart Assoc. 2019 Dec 17;8(24):e013870. doi: 10.1161/JAHA.119.013870. Epub 2019 Dec 10. J Am Heart Assoc. 2019. PMID: 31818215 Free PMC article.
-
Optimal Revascularization Strategy in Non-ST-Segment-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease: Culprit-Only Versus One-Stage Versus Multistage Revascularization.J Am Heart Assoc. 2020 Aug 4;9(15):e016575. doi: 10.1161/JAHA.120.016575. Epub 2020 Jul 31. J Am Heart Assoc. 2020. PMID: 32750302 Free PMC article.
Cited by
-
Complications and Outcomes of Impella Treatment in Cardiogenic Shock Patients With and Without Acute Myocardial Infarction.J Am Heart Assoc. 2023 Sep 5;12(17):e030819. doi: 10.1161/JAHA.123.030819. Epub 2023 Aug 30. J Am Heart Assoc. 2023. PMID: 37646217 Free PMC article.
-
Comparison of Angiographic Success and Clinical Outcomes Based on Different Percutaneous Coronary Intervention Techniques.Cureus. 2024 Sep 13;16(9):e69342. doi: 10.7759/cureus.69342. eCollection 2024 Sep. Cureus. 2024. PMID: 39398674 Free PMC article.
-
β-Blocker Therapy After Myocardial Infarction: A Little Goes a Long Way.J Am Heart Assoc. 2023 Aug;12(15):e030867. doi: 10.1161/JAHA.123.030867. Epub 2023 Jul 26. J Am Heart Assoc. 2023. PMID: 37493027 Free PMC article. No abstract available.
-
Functional and morphological improvement of significant non-culprit coronary artery stenosis by LDL-C reduction with a PCSK9 antibody: Rationale and design of the randomized FITTER trial.Heliyon. 2024 Sep 18;10(19):e38077. doi: 10.1016/j.heliyon.2024.e38077. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39430462 Free PMC article.
-
Clinical Review of Cardiogenic Shock After Acute Myocardial Infarction - Revascularization, Mechanical Circulatory Support, and Beyond.Circ Rep. 2024 Nov 29;7(1):6-14. doi: 10.1253/circrep.CR-24-0141. eCollection 2025 Jan 10. Circ Rep. 2024. PMID: 39802125 Free PMC article. Review.
References
-
- Puymirat E, Simon T, Cayla G, et al. Acute myocardial infarction: changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015. Circulation. 2017;136:1908–1919. doi: 10.1161/CIRCULATIONAHA.117.030798. - DOI - PubMed
-
- Chacko L, Howard PJ, Rajkumar C, et al. Effects of percutaneous coronary intervention on death and myocardial infarction stratified by stable and unstable coronary artery disease: a meta-analysis of randomized controlled trials. Circ Cardiovasc Qual Outcomes. 2020;13:e006363. doi: 10.1161/CIRCOUTCOMES.119.006363. - DOI - PMC - PubMed
-
- Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2022;145:e18–114. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical